Relapsing polychondritis-associated meningoencephalitis initially presenting as seizure: a case report and literature review.
immunosuppressants
inflammatory meningoencephalitis
neuroimmune disease
relapsing polychondritis
seizure
Journal
Frontiers in neurology
ISSN: 1664-2295
Titre abrégé: Front Neurol
Pays: Switzerland
ID NLM: 101546899
Informations de publication
Date de publication:
2023
2023
Historique:
received:
26
07
2023
accepted:
19
10
2023
medline:
30
11
2023
pubmed:
30
11
2023
entrez:
30
11
2023
Statut:
epublish
Résumé
Relapsing polychondritis (RP) is a rare rheumatologic disorder that may affect the neurological system with various presentations. In this study, we present a case and summarize the clinical characteristics of RP-associated meningoencephalitis. A 48-year-old man presented with first-ever seizures that were well controlled by valproate. Physical examination results were unremarkable, except for binaural deformation. The initial brain magnetic resonance imaging (MRI) without contrast and electroencephalogram (EEG) findings were normal. However, the patient subsequently developed recurrent fever, scleritis, headache, lethargy, and left arm paresis. Repeated brain MRI with contrast demonstrated increased enhancement of the pia mater and abnormal diffusion-weighted imaging (DWI) signals in the bilateral auricles. The cerebrospinal fluid (CSF) analysis showed 2 leukocytes/μL, 736.5 mg/L of protein, and no evidence of infectious disease or autoimmune encephalitis. Meningoencephalitis secondary to RP was considered. The patient's condition improved significantly and quickly with the administration of dexamethasone (10 mg per day). Oral methylprednisolone was continued, and the patient remained well without relapse during the 9-month follow-up period. RP-associated meningoencephalitis is rare but fatal. Although symptoms vary, red or deformed ears remain the most common and suggestive features. Non-specific parenchymal changes and/or meningeal enhancement can be observed on brain MRI scans. CSF lymphocytic pleocytosis with mild protein elevation was observed in most patients.
Sections du résumé
Background and purpose
UNASSIGNED
Relapsing polychondritis (RP) is a rare rheumatologic disorder that may affect the neurological system with various presentations. In this study, we present a case and summarize the clinical characteristics of RP-associated meningoencephalitis.
Case presentation
UNASSIGNED
A 48-year-old man presented with first-ever seizures that were well controlled by valproate. Physical examination results were unremarkable, except for binaural deformation. The initial brain magnetic resonance imaging (MRI) without contrast and electroencephalogram (EEG) findings were normal. However, the patient subsequently developed recurrent fever, scleritis, headache, lethargy, and left arm paresis. Repeated brain MRI with contrast demonstrated increased enhancement of the pia mater and abnormal diffusion-weighted imaging (DWI) signals in the bilateral auricles. The cerebrospinal fluid (CSF) analysis showed 2 leukocytes/μL, 736.5 mg/L of protein, and no evidence of infectious disease or autoimmune encephalitis. Meningoencephalitis secondary to RP was considered. The patient's condition improved significantly and quickly with the administration of dexamethasone (10 mg per day). Oral methylprednisolone was continued, and the patient remained well without relapse during the 9-month follow-up period.
Conclusion
UNASSIGNED
RP-associated meningoencephalitis is rare but fatal. Although symptoms vary, red or deformed ears remain the most common and suggestive features. Non-specific parenchymal changes and/or meningeal enhancement can be observed on brain MRI scans. CSF lymphocytic pleocytosis with mild protein elevation was observed in most patients.
Identifiants
pubmed: 38033767
doi: 10.3389/fneur.2023.1265345
pmc: PMC10682709
doi:
Types de publication
Systematic Review
Langues
eng
Pagination
1265345Informations de copyright
Copyright © 2023 Zhang, Shi, Zhang, Wang and Shao.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
J Clin Neurosci. 2011 Dec;18(12):1608-15
pubmed: 22051026
Intern Med. 2015;54(2):231-4
pubmed: 25743018
J Neurol Neurosurg Psychiatry. 2004 Nov;75(11):1646-7
pubmed: 15489409
Rinsho Shinkeigaku. 2009 Apr;49(4):172-8
pubmed: 19462815
Prog Neuropsychopharmacol Biol Psychiatry. 2005 Feb;29(2):347-9
pubmed: 15694246
Neuroimmunomodulation. 2020;27(1):69-74
pubmed: 32101879
Rheumatol Int. 2018 Nov;38(11):2095-2101
pubmed: 30084004
Neurology. 2022 Feb 8;98(6):e677-e678
pubmed: 34862316
J Neurol Sci. 2004 May 15;220(1-2):85-8
pubmed: 15140611
Best Pract Res Clin Rheumatol. 2016 Apr;30(2):316-333
pubmed: 27886803
Medicine (Baltimore). 2021 Jun 18;100(24):e26315
pubmed: 34128872
Rheumatology (Oxford). 2011 Sep;50(9):1721-3
pubmed: 21622521
J Clin Rheumatol. 2011 Sep;17(6):329-31
pubmed: 21869705
No Shinkei Geka. 2012 Mar;40(3):247-53
pubmed: 22392754
Case Rep Neurol Med. 2018 Oct 3;2018:1873582
pubmed: 30402308
Clin Rheumatol. 2007 Nov;26(11):1985-8
pubmed: 17404785
Fortschr Neurol Psychiatr. 2012 Aug;80(8):463-7
pubmed: 22777885
Am J Forensic Med Pathol. 2022 Sep 1;43(3):263-268
pubmed: 35642781
Rev Bras Reumatol Engl Ed. 2017 Nov - Dec;57(6):623-625
pubmed: 29173700
Medicine (Baltimore). 1976 May;55(3):193-215
pubmed: 775252
Intern Med. 2020 May 15;59(10):1339-1340
pubmed: 32051378
Intern Med. 2016;55(9):1191-3
pubmed: 27150878
BMC Neurol. 2018 Apr 25;18(1):53
pubmed: 29699514
Joint Bone Spine. 2010 Dec;77(6):619-20
pubmed: 20621534
Rev Bras Reumatol Engl Ed. 2017 Jul - Aug;57(4):338-345
pubmed: 28743361
Laryngoscope. 1979 Jun;89(6 Pt 1):929-46
pubmed: 449538
Intern Med. 2023 Feb 1;62(3):481-486
pubmed: 35831110
J Neurol Neurosurg Psychiatry. 2008 May;79(5):609-10
pubmed: 18208859
Ann Intern Med. 1986 Jan;104(1):74-8
pubmed: 3484422
J Korean Med Sci. 2016 Nov;31(11):1846-1850
pubmed: 27709866
Cutis. 2017 Jan;99(1):43-46
pubmed: 28207003